Company: IMRX
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001790340-25-000135
Chunk: 320

Company: Immuneering Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 1A
Chunk 320
---
 and similar activities, subject to certain customary exceptions and fall-away provisions, and (iii) until the first anniversary of the closing date of the September 2025 Private Placement or such earlier time as the stand-still restrictions shall have fallen away, vote with respect to all of our voting securities as to which it is entitled to vote in accordance with the recommendation of a majority of our board of directors.

The foregoing and other related summaries contained herein do not purport to be complete and are qualified in their entirety by reference to the September 2025 Purchase Agreement, which is filed as Exhibit 10.5 to this Quarterly Report on Form 10-Q.

Use of Proceeds

We intend to use the net proceeds from the August 2025 Private Placement and the September 2025 Private Placement to advance the preclinical and clinical development of our product candidates and for working capital and other general corporate purposes.

Issuer Purchases of Equity Securities

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable

99

Table of Contents

Item 5. Other Information

(a) Disclosure in lieu of reporting on a Current Report on Form 8-K.

      None.

(b) Material changes to the procedures by which security holders may recommend nominees to the board of directors.

      None.

(c) Insider Trading Arrangements and Policies

During the three months ended September 30, 2025, no director or “officer” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits

EXHIBIT INDEX

Incorporated by ReferenceFiled/FurnishedHerewithExhibit NumberExhibit DescriptionFormFile No.ExhibitFilingDate3.1Amended and Restated Certificate of Incorporation of Immuneering Corporation10-Q001-406753.19/9/20213.2Amended and Restated Bylaws of Immuneering Corporation8-K001-406753.12/2/20244.1Form of Pre-Funded Warrant8-K001-406754.18/25/20254.2Form of Purchase Warrant8-K001-406754.28/25/202510.1#Immuneering Corporation Non-Employee Director